QQ客服 官方微博 反馈留言

	Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis
	Yin Chengqian[1]; Zhu Bo[2]; Zhang Ting[3]; Liu Tongzheng[4]; Chen Shuyang[5]; Liu Yu[6]; Li Xin[7]; Miao Xiao[8]; Li Shanshan[9]; Mi Xia[10]
刊名	Cell
	2019
卷号	176页码:1113-1127.e16
关键词	NRAS RAS STK19 cancer drug screening kinase inhibitor melanoma melanomagenesis targeted cancer therapy
ISSN号	1097-4172
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2164187
专题	上海大学
作者单位	1.[1]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. 2.[2]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. 3.[3]State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, 361102 Fujian, China. 4.[4]Jinan University Institute of Tumor Pharmacology, Guangzhou, 510632 Guangdong, China. 5.[5]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. 6.[6]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041 Sichuan, China. 7.[7]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. 8.[8]Innovation Research Institute of traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200000 Shanghai, China. 9.[9]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. 10.[10]Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
推荐引用方式 GB/T 7714	Yin Chengqian[1],Zhu Bo[2],Zhang Ting[3],et al. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis[J]. Cell,2019,176:1113-1127.e16.
APA	Yin Chengqian[1].,Zhu Bo[2].,Zhang Ting[3].,Liu Tongzheng[4].,Chen Shuyang[5].,...&Cui Rutao[21].(2019).Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.Cell,176,1113-1127.e16.
MLA	Yin Chengqian[1],et al."Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis".Cell 176(2019):1113-1127.e16.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。